Innovation ARDEAPHARMA, a.s. (Q9941): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): ARDEAPHARMA, a.s. is a pharmaceutical company in the category of small enterprise, which has Czech owners and is the only one of its kind operating on the Czech market alongside multinational pharmaceutical corporations. In almost 20-year history, it has shown a positive economy and has not yet received financial support from EU funds. The project is focused on innovation of products and related innovation of the company’s production and control...) |
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
||
| description / en | description / en | ||
Project in Czech Republic | Project Q9941 in Czech Republic | ||
| description / cs | description / cs | ||
Projekt v | Projekt Q9941 v Czechia | ||
Revision as of 15:23, 28 October 2020
Project Q9941 in Czech Republic
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Innovation ARDEAPHARMA, a.s. |
Project Q9941 in Czech Republic |
Statements
6,300,000.0 Czech koruna
0 references
14,000,000.0 Czech koruna
0 references
45 percent
0 references
21 September 2015
0 references
19 September 2018
0 references
20 September 2018
0 references
ARDEAPHARMA, a.s.
0 references
49°5'42.72"N, 14°33'56.70"E
0 references
37363
0 references
ARDEAPHARMA, a.s. je farmaceutická společnost v kategorii malý podnik, která má české vlastníky a jako jediná svého druhu působí na českém trhu vedle nadnárodních farmaceutických korporací. V téměř 20-leté historii vykazuje kladné hospodaření a dosud nečerpala finanční podporu z fondů EU. Projekt je zaměřen na inovaci výrobků a související inovaci výrobního a kontrolního procesu společnosti, s cílem posílit konkurenceschopnost jak na domácím trhu, tak i směrem k zahraničí. a. (Czech)
0 references
ARDEAPHARMA, a.s. is a pharmaceutical company in the category of small enterprise, which has Czech owners and is the only one of its kind operating on the Czech market alongside multinational pharmaceutical corporations. In almost 20-year history, it has shown a positive economy and has not yet received financial support from EU funds. The project is focused on innovation of products and related innovation of the company’s production and control process in order to strengthen competitiveness both on the domestic market and towards abroad. a. (English)
22 October 2020
0 references
Identifiers
CZ.01.1.02/0.0/0.0/15_014/0004450
0 references